---
figid: PMC5114830__40478_2016_392_Fig1_HTML
figlink: /pmc/articles/PMC5114830/figure/Fig1/
number: Fig. 1
caption: "a  Group 1. 1) RyR1 open (voltage-gated): RyR1 activation in response to
  DHPR activation by acetylcholine (ACh) release at the neuromuscular junction in
  skeletal muscle 2) RyR1 closed: no neuromuscular-stimulated ACh release. b  Group
  2. 1) RyR1 open: No interdomain interaction (unzipped) with bound ApoCaM in response
  to RyR1 activation preceded by DHPR activation resulting in high sarcoplasmic Ca\uFEFF2+\uFEFF
  2) RyR1 closed: bound Ca2+-Cam at high [Ca2+] resulting in interdomain interaction
  (zipped) and\uFEFF \uFEFFhigh sarcoplasmic reticulum (S\uFEFFR) Ca\uFEFF2+. c  Group
  3. 1) RyR1 open: RyR1-triadin interaction due to triadin-calsequestrin (CSQ) interaction
  at high Ca2+ bound CSQ resulting in high sarcoplasmic Ca\uFEFF2+ 2) RyR1 closed:
  RyR1-junctin interaction due to junctin-CSQ interaction at low Ca2+ bound CSQ in
  phosphorylated state  resulting in high SR Ca\uFEFF2+. d  Group 4. 1) RyR1 open:
  RyR1 and Gm phosphorylation by PKA due to high [cAMP] re\uFEFFsulting in high sar\uFEFFcoplasmic
  Ca\uFEFF2+ 2) RyR1 closed: RyR1 dephosphorylation by PP1 due to low [cAMP] resulting
  in high SR Ca\uFEFF2+. e  Group 5. S-nitrosylation. 1) RyR1 open: nitrosylation
  of RyR1 cysteine residues by nitric oxide-glutathione reaction in response to physiologic
  p(O2)  resulting in high sarcoplasmic Ca\uFEFF2+2) RyR1 open: nitrosylation of RyR1
  by nitric oxide overrides Ca-CaM inhibitory effect resulting in high sarcoplasmic
  Ca\uFEFF2+S-oxidation. 1) RyR1 open: oxidation of RyR1 cysteine residues by reactive
  oxygen species reaction in response to increased physiologic p(O2) resulting in
  high sarcoplasmic Ca\uFEFF2+ 2) RyR1 closed: no RyR1 oxidation at low physiologic
  p(O2) with bound Ca2+-CaM res\uFEFFulting in \uFEFFhigh SR Ca\uFEFF2+ S-glutathionylation.
  1) RyR1 open: initial increase in reduced glutathione (GSH) stimulating glutathionylation
  of RyR1 cysteine residues by GSH, in turn, decreasing the GSH:GSSG and reducing
  RyR1 sensitivity to Mg2+ inhibition resulting in high sarcoplasmic Ca\uFEFF2+ 2)
  RyR1 closed: no glutathionylation until GSH:GSSG ratio is restored res\uFEFFulting
  in high SR Ca\uFEFF2+S-palmitoylation. 1) RyR1 open: palmitoylation of RyR1 cysteine
  residues by the fatty acid palmitoyl-CoA resulting in high sarcoplasmic Ca\uFEFF2+2)
  RyR1 closed: no palmitoylation resulting in high SR Ca\uFEFF2+. f  Group 6. 1) RyR1
  open: RyR1-ligand (Ca2+and ATP) binding activation resulting in high sarcoplasmic
  Ca\uFEFF2+ 2) RyR1 closed: RyR1-ligand (Ca2+ and Mg2+) binding deactivation resulting
  in high SR Ca\uFEFF2+"
pmcid: PMC5114830
papertitle: Review of RyR1 pathway and associated pathomechanisms.
reftext: Jessica W. Witherspoon, et al. Acta Neuropathol Commun. 2016;4:121.
pmc_ranked_result_index: '176715'
pathway_score: 0.9259833
filename: 40478_2016_392_Fig1_HTML.jpg
figtitle: Ryanodine receptor isoform-1 (RyR1) pathway
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5114830__40478_2016_392_Fig1_HTML.html
  '@type': Dataset
  description: "a  Group 1. 1) RyR1 open (voltage-gated): RyR1 activation in response
    to DHPR activation by acetylcholine (ACh) release at the neuromuscular junction
    in skeletal muscle 2) RyR1 closed: no neuromuscular-stimulated ACh release. b
    \ Group 2. 1) RyR1 open: No interdomain interaction (unzipped) with bound ApoCaM
    in response to RyR1 activation preceded by DHPR activation resulting in high sarcoplasmic
    Ca\uFEFF2+\uFEFF 2) RyR1 closed: bound Ca2+-Cam at high [Ca2+] resulting in interdomain
    interaction (zipped) and\uFEFF \uFEFFhigh sarcoplasmic reticulum (S\uFEFFR) Ca\uFEFF2+.
    c  Group 3. 1) RyR1 open: RyR1-triadin interaction due to triadin-calsequestrin
    (CSQ) interaction at high Ca2+ bound CSQ resulting in high sarcoplasmic Ca\uFEFF2+
    2) RyR1 closed: RyR1-junctin interaction due to junctin-CSQ interaction at low
    Ca2+ bound CSQ in phosphorylated state  resulting in high SR Ca\uFEFF2+. d  Group
    4. 1) RyR1 open: RyR1 and Gm phosphorylation by PKA due to high [cAMP] re\uFEFFsulting
    in high sar\uFEFFcoplasmic Ca\uFEFF2+ 2) RyR1 closed: RyR1 dephosphorylation by
    PP1 due to low [cAMP] resulting in high SR Ca\uFEFF2+. e  Group 5. S-nitrosylation.
    1) RyR1 open: nitrosylation of RyR1 cysteine residues by nitric oxide-glutathione
    reaction in response to physiologic p(O2)  resulting in high sarcoplasmic Ca\uFEFF2+2)
    RyR1 open: nitrosylation of RyR1 by nitric oxide overrides Ca-CaM inhibitory effect resulting
    in high sarcoplasmic Ca\uFEFF2+S-oxidation. 1) RyR1 open: oxidation of RyR1 cysteine
    residues by reactive oxygen species reaction in response to increased physiologic
    p(O2) resulting in high sarcoplasmic Ca\uFEFF2+ 2) RyR1 closed: no RyR1 oxidation
    at low physiologic p(O2) with bound Ca2+-CaM res\uFEFFulting in \uFEFFhigh SR
    Ca\uFEFF2+ S-glutathionylation. 1) RyR1 open: initial increase in reduced glutathione
    (GSH) stimulating glutathionylation of RyR1 cysteine residues by GSH, in turn,
    decreasing the GSH:GSSG and reducing RyR1 sensitivity to Mg2+ inhibition resulting
    in high sarcoplasmic Ca\uFEFF2+ 2) RyR1 closed: no glutathionylation until GSH:GSSG
    ratio is restored res\uFEFFulting in high SR Ca\uFEFF2+S-palmitoylation. 1) RyR1
    open: palmitoylation of RyR1 cysteine residues by the fatty acid palmitoyl-CoA
    resulting in high sarcoplasmic Ca\uFEFF2+2) RyR1 closed: no palmitoylation resulting
    in high SR Ca\uFEFF2+. f  Group 6. 1) RyR1 open: RyR1-ligand (Ca2+and ATP) binding
    activation resulting in high sarcoplasmic Ca\uFEFF2+ 2) RyR1 closed: RyR1-ligand
    (Ca2+ and Mg2+) binding deactivation resulting in high SR Ca\uFEFF2+"
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - QDPR
  - KRIT1
  - FKBP1A
  - FGFR3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - NOS1
  - PRKACG
  - NOS2
  - NOS3
  - RYR1
  - NOX4
  - CysCys
  - Cys
  - Cys Cys-Cys
  - Cys SNO
  - GSH GSSG
genes:
- word: DHPR
  symbol: DHPR
  source: hgnc_alias_symbol
  hgnc_symbol: QDPR
  entrez: '5860'
- word: CaM
  symbol: CAM
  source: hgnc_alias_symbol
  hgnc_symbol: KRIT1
  entrez: '889'
- word: FKBP12
  symbol: FKBP-12
  source: hgnc_alias_symbol
  hgnc_symbol: FKBP1A
  entrez: '2280'
- word: ACh
  symbol: ACH
  source: hgnc_prev_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: NNOS
  symbol: nNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS1
  entrez: '4842'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS1
  entrez: '4842'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: nNOS
  symbol: nNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS1
  entrez: '4842'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS2
  entrez: '4843'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: RyR1
  symbol: RYR1
  source: hgnc_symbol
  hgnc_symbol: RYR1
  entrez: '6261'
- word: Nox4
  symbol: NOX4
  source: hgnc_symbol
  hgnc_symbol: NOX4
  entrez: '50507'
chemicals:
- word: CysCys
  source: MESH
  identifier: C046557
- word: Cys
  source: MESH
  identifier: D003545
- word: Cys Cys-Cys
  source: MESH
  identifier: D003545
- word: Cys SNO
  source: MESH
  identifier: D003545
- word: GSH GSSG
  source: MESH
  identifier: D019803
diseases: []
---
